An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: Application to cystic fibrosis

Molecular and Cellular Proteomics

Volumn 4, Issue 8, 2005, Pages 1052-1060

  Pedersen, Susanne K ^a   Sloane, Andrew J ^a   Prasad, Sindhu S ^a   Sebastian, Lucille T ^a   Lindner, Robyn A ^a   Hsu, Michael ^a   Robinson, Michael ^b   Bye, Peter T ^b   Weinberger, Ron P ^a   Harry, Jenny L ^a  

^a Proteome Systems Ltd   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BACTERIAL PROTEIN; BIOCHEMICAL MARKER; CALGRANULIN; CHAPERONIN; IRON BINDING PROTEIN; MYELOPEROXIDASE; NUCLEOSIDE DIPHOSPHATE KINASE; THIOREDOXIN;

AMINO ACID SEQUENCE; ANTIBODY ISOLATION; ANTIGEN DETECTION; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL PNEUMONIA; BODY FLUID; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE MARKER; HUMAN; IMMUNOASSAY; IN VIVO STUDY; LUNG FIBROSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEOMICS; PSEUDOMONAS AERUGINOSA; SCREENING TEST; SPUTUM ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; ALGINATES; AUTOANTIGENS; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CYSTIC FIBROSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENOTYPE; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MIDDLE AGED; PROTEOMICS; PSEUDOMONAS AERUGINOSA; SPUTUM;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 24044544188     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M400175-MCP200     Document Type: Article

References (52)

1. Wulfkuhle, J. D., Paweletz, C. P., Steeg, P. S., Petricoin, E. F., III, and Liotta, L. (2003) Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv. Exp. Med. Biol. 532, 59-68
2. Rohlff, C., and Southan, C. (2002) Proteomic approaches to central nervous system disorders. Curr. Opin. Mol. Ther. 4, 251-258
3. Herbert, B., and Righetti, P. G. (2000) A turning point in proteome analysis: sample prefractionation via multicompartment electrolyzers with isoelectric membranes. Electrophoresis 21, 3639-3648
4. Pedersen, S. K., Harry, J. L., Sebastian, L., Baker, J., Traini, M. D., McCarthy, J. T., Manoharan, A., Wilkins, M. R., Gooley, A. A., Righetti, P. G., Packer, N. H., Williams, K. L., and Herbert, B. R. (2003) Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins. J. Proteome Res. 2, 303-311
5. Brichory, F., Beer, D., Le Naour, F., Giordano, T., and Hanash, S. (2001) Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res. 61, 7908-7912
6. Pitarch, A., Pardo, M., Jimenez, A., Pla, J., Gil, C., Sanchez, M., and Nombela, C. (1999) Two-dimensional gel electrophoresis as analytical tool for identifying Candida albicans immunogenic proteins. Electrophoresis 20, 1001-1010
7. van Stipdonk, M. J., Willems, A. A., Amor, S., Persoon-Deen, C., Travers, P. J., Boog, C. J., and Van Noort, J. M. (1998) T cells discriminate between differentially phosphorylated forms of αB-crystallin, a major central nervous system myelin antigen. Int. Immunol. 10, 943-950
8. Line, A., Stengrevics, A., Slucka, Z., Li, G., Jankevics, E., and Rees, R. C. (2002) Serological identification and expression analysis of gastric cancer-associated genes. Br. J. Cancer 86, 1824-1830
9. Krah, A., and Jungblut, P. R. (2004) Immunoproteomics Methods Mol. Med. 94, 19-32
10. Brichory, F. M., Misek, D. E., Yim, A. M., Krause, M. C., Giordano, T. J., Beer, D. G., and Hanash, S. M. (2001) An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl. Acad. Sci. U. S. A. 98, 9824-9829
11. Le Naour, F. (2001) Contribution of proteomics to tumor immunology. Proteomics 1, 1295-1302
12. Mintz, P. J., Kim, J., Do, K. A., Wang, X., Zinner, R. G., Cristofanilli, M., Arap, M. A., Hong, W. K., Troncoso, P., Logothetis, C. J., Pasqualini, R., and Arap, W. (2003) Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat. Biotechnol. 21, 57-63
13. Kersten, B., Feilner, T., Kramer, A., Wehrmeyer, S., Possling, A., Witt, I., Zanor, M. I., Stracke, R., Lueking, A., Kreutzberger, J., Lehrach, H., and Cahill, D. J. (2003) Generation of Arabidopsis protein chips for antibody and serum screening. Plant Mol. Biol. 52, 999-1010
14. Sloane, A. J., Duff, J. L., Wilson, N. L., Gandhi, P. S., Hill, C. J., Hopwood, F. G., Smith, P. E., Thomas, M. L., Cole, R. A., Packer, N. H., Breen, E. J., Cooley, P. W., Wallace, D. B., Williams, K. L., and Gooley, A. A. (2002) High throughput peptide mass fingerprinting and protein macroarray analysis using chemical printing strategies. Mol. Cell. Proteomics 1, 490-499
15. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J. L., Drumm, M. L., Iannuzzi, M. C., Collins, F. S., and Tsui, L. C. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073
16. Gibson, R. L., Burns, J. L., and Ramsey, B. W. (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168, 918-951
17. Fahy, J. V., Wong, H., Liu, J., and Boushey, H. A. (1995) Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects. Am. J. Respir. Crit. Care Med. 152, 53-58
18. Rosenfeld, M., Emerson, J., Williams-Warren, J., Pepe, M., Smith, A., Montgomery, A. B., and Ramsey, B. (2001) Defining a pulmonary exacerbation in cystic fibrosis. J. Pediatr. 139, 359-365
19. Dakin, C., Henry, R. L., Field, P., and Morton, J. (2001) Defining an exacerbation of pulmonary disease in cystic fibrosis. Pediatr. Pulmonol. 31, 436-442
20. Katayama, H., Nagasu, T., and Oda, Y. (2001) Improvement of in-gel digestion protocol for peptide mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 15, 1416-1421
21. Kussmann, M., Lassing, U., Sturmer, C. A., Przybylski, M., and Roepstorff, P. (1997) Matrix-assisted laser desorption/ionization mass spectrometric peptide mapping of the neural cell adhesion protein neurolin purified by sodium dodecyl sulfate polyacrylamide gel electrophoresis or acidic precipitation. J. Mass Spectrom. 32, 483-493
22. Breen, E. J., Hopwood, F., Williams, K. L., and Wilkins, M. R. (2000) Automatic Poisson peak harvesting for high throughput protein identification. Electrophoresis 21, 2243-2251
23. Wang, D., Kalb, S. R., and Cotter, R. J. (2004) Improved procedures for N-terminal sulfonation of peptides for matrix-assisted laser desorption/ionization post-source decay peptide sequencing. Rapid Commun. Mass Spectrom. 18, 96-102
24. Zhao, M. H., Jayne, D. R., Ardiles, L. G., Culley, F., Hodson, M. E., and Lockwood, C. M. (1996) Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM 89, 259-265
25. Carlsson, M., Eriksson, L., Erwander, I., Wieslander, J., and Segelmark, M. (2003) Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin. Exp. Rheumatol. 21, S95-S100
26. Barthe, C., Figarella, C., Carrere, J., and Guy-Crotte, O. (1991) Identification of 'cystic fibrosis protein' as a complex of two calcium-binding proteins present in human cells of myeloid origin. Biochim. Biophys. Acta 1096, 175-177
27. Bartunkova, J., Tesar, V., and Sediva, A. (2003) Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies. Clin. Immunol. 106, 73-82
28. Kallenberg, C. G., Brouwer, E., Mulder, A. H., Stegeman, C. A., Weening, J. J., and Tervaert, J. W. (1995) ANCA-pathophysiology revisited. Clin. Exp. Immunol. 100, 1-3
29. Lee, K. H., Chung, H. S., Kim, H. S., Oh, S. H., Ha, M. K., Baik, J. H., Lee, S., and Bang, D. (2003) Human α-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum. 48, 2025-2035
30. Husby, G. (2000) Is there a pathogenic link between γ heavy chain disease and chronic arthritis? Curr. Opin. Rheumatol. 12, 65-70
31. Pawel-Rammingen, U., Johansson, B. P., and Bjorck, L. (2002) IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21, 1607-1615
32. Guignard, F., Mauel, J., and Markert, M. (1996) Phosphorylation of myeloid-related proteins MRP-14 and MRP-8 during human neutrophil activation. Eur. J. Biochem. 241, 265-271
33. Fick, R. B., Naegel, G. P., Squier, S. U., Wood, R. E., Gee, J. B., and Reynolds, H. Y. (1984) Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis J. Clin. Investig. 74, 236-248
34. Zhou, H., Lu, F., Latham, C., Zander, D. S., and Visner, G. A. (2004) Heme oxygenase-1 expression in human lungs with cystic fibrosis and cytoprotective effects against Pseudomonas aeruginosa in vitro. Am. J. Respir. Crit. Care Med. 170, 633-640
35. Singh, S. K., and Girschick, H. J. (2004) Lyme borreliosis: from infection to autoimmunity. Clin. Microbiol. Infect. 10, 598-614
36. Warnock, M. G., and Goodacre, J. A. (1997) Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases. Br. J. Rheumatol. 36, 1144-1150
37. Lo, W. F., Woods, A. S., DeCloux, A., Cotter, R. J., Metcalf, E. S., and Soloski, M. J. (2000) Molecular mimicry mediated by MHC class lb molecules after infection with Gram-negative pathogens. Nat. Med. 6, 215-218
38. Gitlits, V. M., Toh, B. H., and Sentry, J. W. (2001) Disease association, origin and clinical relevance to autoantibodies to the glycolytic enzyme enolase. J. Investig. Med. 49, 138-145
39. Gitlits, V. M., Sentry, J. W., Matthew, M. L., Smith, A. I., and Toh, B. H. (1997) Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus. Immunology 92, 362-368
40. Jacobs, E., Bartl, A., Oberle, K., and Schiltz, E. (1995) Molecular mimicry by Mycoplasma pneumoniae to evade the induction of adherence inhibiting antibodies. J. Med. Microbiol. 43, 422-429
41. Ikenoya, H., Ishihara, K., and Okuda, K. (2001) Cloning and characterization of a gene encoding an immunosuppressive factor from Actinobacillus actinomycetemcomitans. Bull. Tokyo Dent. Coll. 42, 65-71
42. Goulhen, F., Grenier, D., and Mayrand, D. (2003) Oral microbial heat-shock proteins and their potential contributions to infections. Crit. Rev. Oral Biol. Med. 14, 399-412
43. Chintalacharuvu, K. R., Chuang, P. D., Dragoman, A., Fernandez, C. Z., Qiu, J., Plaut, A. G., Trinh, K. R., Gala, F. A., and Morrison, S. L. (2003) Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infect. Immun. 71, 2563-2570
44. Littlewood, J. M., Bevan, A., Connett, G., Conway, S., Dodd, M., Govan, J., Hodson, M. E., Madge, S., Livermore, D., Smyth, R., and Webb, K. (2002) Antibiotic Treatment for Cystic Fibrosis. Report of the UK Cystic Fibrosis Trust Antibiotic Group, 2nd Ed., Cystic Fibrosis Trust, Kent, UK
45. Brett, M. M., Ghoneim, A. T., and Littlewood, J. M. (1986) Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis. Arch. Dis. Child 61, 1114-1120
46. Brett, M. M., Ghoneim, A. T., Littlewood, J. M., and Losowsky, M. S. (1986) Development of enzyme linked immunosorbent assay (ELISA) to detect antibodies to Pseudomonas aeruginosa cell surface antigens in sera of patients with cystic fibrosis. J. Clin. Pathol. 39, 1124-1129
47. Delic-Attree, I., Toussaint, B., Garin, J., and Vignais, P. M. (1997) Cloning, sequence and mutagenesis of the structural gene of Pseudomonas aeruginosa CysB, which can activate algD transcription. Mol. Microbiol. 24, 1275-1284
48. Chakrabarty, A. M. (1998) Nucleoside diphosphate kinase: role in bacterial growth, virulence, cell signalling and polysaccharide synthesis. Mol. Microbiol. 28, 875-882
49. Schlictman, D., Kubo, M., Shankar, S., and Chakrabarty, A. M. (1995) Regulation of nucleoside diphosphate kinase and secretable virulence factors in Pseudomonas aeruginosa: Roles of algR2 and algH. J. Bacteriol. 177, 2469-2474
50. Malhotra, S., Silo-Suh, L. A., Mathee, K., and Ohman, D. E. (2000) Proteome analysis of the effect of mucoid conversion on global protein expression in Pseudomonas aeruginosa strain PAO1 shows induction of the disulfide bond isomerase, dsbA. J. Bacteriol. 182, 6999-7006
51. Nouwens, A. S., Willcox, M. D., Walsh, B. J., and Cordwell, S. J. (2002) Proteomic comparison of membrane and extracellular proteins from invasive (PAO1) and cytotoxic (6206) strains of Pseudomonas aeruginosa. Proteomics 2, 1325-1346
52. Clarke, L., Moore, J. E., Millar, B. C., Garske, L., Xu, J., Heuzenroeder, M. W., Crowe, M., and Elborn, J. S. (2003) Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients. J. Med. Microbiol. 52, 759-763